GlassScriptPhysician profile
Jeanne E Holdren
NPI 1497860811
$4,887.18
in general payments reported to CMS, 2019-2025
17 companies · $1,265 in 2025
The $1,265 reported for 2025 was more than what 85% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $923 · 2022: $779 · 2023: $810 · 2024: $1,109 · 2025: $1,265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,184.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,209.51 | 2021-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $936.40 | 2021-2025 | Caplyta |
| Alkermes, INC. | $904.04 | 2021-2025 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $483.21 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $317.62 | 2021-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $276.99 | 2021-2025 | Invega Sustenna, Spravato |
| E.R. Squibb & Sons, L.L.C. | $222.69 | 2024-2025 | Cobenfy |
| Lundbeck LLC | $126.73 | 2022-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $113.02 | 2024-2025 | Fanapt |
| Abbvie INC. | $95.11 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $65.88 | 2022 | |
| Collegium Pharmaceutical, INC. | $31.32 | 2025 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $31.00 | 2021-2022 | |
| Axsome Therapeutics, INC. | $23.33 | 2025 | Auvelity |
| Ironshore Pharmaceuticals INC. | $20.93 | 2023 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.57 | 2025 | |
| Lilly USA, LLC | $12.83 | 2023 | Mounjaro, Trulicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Holdren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.